Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04660539 |
|---|---|
| Brief Title: | A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD) |
| First Submitted : | November 24, 2020 |
| First Submitted that Met QC Criteria : | December 7, 2020 |
| First Posted : | December 9, 2020 |
| Last Update Submitted that Met QC Criteria : | December 7, 2022 |
| Last Update Posted : | December 8, 2022 |